#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	7774	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2881	639.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1867	1867	C	979	C,A,T,G	863,3,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	14040	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4197	796.8	0	.	n	.	0	T695C	SNP	695	695	T	1296	1296	C	908	C,A,G	821,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	14040	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4197	796.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1938	1938	A	941	A,G	864,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	14040	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4197	796.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2572	2572	C	1054	C,T,G	966,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	14040	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4197	796.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2646	2646	A	1108	A,C	999,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	14040	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4197	796.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	3198	3198	C	1141	C,A	1016,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	1290	folP	852	852	100.0	folP.l6.c17.ctg.1	2110	143.7	1	SNP	p	R228S	1	.	.	682	684	AGC	1314	1316	AGC	185;184;180	A;G;C,G	166;167;161,1	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	2632	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3990	156.9	1	SNP	p	S91F	0	.	.	271	273	TCC	940	942	TCC	170;170;170	T;C;C	145;149;151	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	2632	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3990	156.9	1	SNP	p	D95N	0	.	.	283	285	GAC	952	954	GAC	181;182;183	G,C;A,G,T;C	159,1;158,1,1;160	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	2632	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3990	156.9	1	SNP	p	D95G	0	.	.	283	285	GAC	952	954	GAC	181;182;183	G,C;A,G,T;C	159,1;158,1,1;160	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	668	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1891	84.9	0	.	p	.	0	A39T	NONSYN	115	117	GCC	675	677	ACC	190;192;187	A;C;C	163;169;165	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	668	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1891	84.9	0	.	p	.	0	R44H	NONSYN	130	132	CGC	690	692	CAC	187;187;190	C;A;C	162;148;163	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	668	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1891	84.9	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	873	875	CAC	165;166;164	C,A;A,C;C,T	144,1;138,7;140,1	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	668	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1891	84.9	1	SNP	p	G45D	0	.	.	133	135	GGC	693	695	GGC	190;190;190	G,C;G;C,A	163,1;164;159,1	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	666	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1791	89.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	2714	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3442	187.5	1	SNP	p	D86N	0	.	.	256	258	GAC	814	816	GAC	190;189;193	G,A;A;C	143,1;112;139	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	2714	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3442	187.5	1	SNP	p	S87R	0	.	.	259	261	AGT	817	819	AGT	193;196;202	A,T;G,C;T,G	134,1;152,1;162,5	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	2714	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3442	187.5	1	SNP	p	S87I	0	.	.	259	261	AGT	817	819	AGT	193;196;202	A,T;G,C;T,G	134,1;152,1;162,5	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	2714	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3442	187.5	1	SNP	p	S87W	0	.	.	259	261	AGT	817	819	AGT	193;196;202	A,T;G,C;T,G	134,1;152,1;162,5	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	2714	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3442	187.5	1	SNP	p	S88P	0	.	.	262	264	TCC	820	822	TCC	203;202;203	T,G;C,T;C,G	169,1;169,4;171,2	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2750	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3298	199.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1879	1881	GGC	217;222;221	G;G,T,C;C	194;196,1,1;194	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	1920	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2469	180.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1465	1467	GCA	243;244;243	G,A;C,G;A,C	211,1;210,1;210,1	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1920	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2469	180.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1468	1470	ATC	244;244;241	A;T,G;C,G	214;218,1;217,1	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1920	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2469	180.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1480	1482	GTG	240;239;239	G;T;G,T,C	214;212;213,1,1	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1920	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2469	180.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1480	1482	GTG	240;239;239	G;T;G,T,C	214;212;213,1,1	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1920	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2469	180.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1984	1986	ACC	164;165;162	A,C;C;C,G	113,1;127;138,1	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1920	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2469	180.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2038	2040	GCG	144;143;142	G;C;G	111;104;104	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1920	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2469	180.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2038	2040	GCG	144;143;142	G;C;G	111;104;104	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1920	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2469	180.2	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2161	2163	GGC	156;158;159	G,C;G,T,C;C,T,G	143,1;141,1,1;137,6,1	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1920	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2469	180.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2170	2172	GGC	150;150;148	G,C;G;C,G,A	134,1;120;97,1,1	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1920	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2469	180.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2188	2190	CCG	149;148;148	C;C,G;G,C,A	117;103,1;122,2,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	2682	ponA	2397	2397	99.96	ponA.l6.c4.ctg.1	3524	174.6	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1695	1697	CTG	263;264;264	C,G,T;T,C;G,C,T	204,8,4;222,9;221,8,4	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	946	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2298	97.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	745	745	C	93	C	74	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1024	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	2423	100.7	0	.	p	.	0	E48G	NONSYN	142	144	GAA	792	794	GGA	165;163;166	G;G;A,C	147;142;148,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1024	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	2423	100.7	0	.	p	.	0	F135L	NONSYN	403	405	TTT	1053	1055	CTT	179;185;186	C;T;T	152;161;164	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1024	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	2423	100.7	0	.	p	.	0	R143G	NONSYN	427	429	AGA	1077	1079	GGA	201;206;206	G,T;G;A	168,1;180;171	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1024	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	2423	100.7	0	.	p	.	0	D171G	NONSYN	511	513	GAT	1161	1163	GGT	215;215;215	G,A,C;G;T,A,G,C	189,1,1;191;186,2,2,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1024	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	2423	100.7	0	.	p	.	0	G189S	NONSYN	565	567	GGC	1215	1217	AGC	190;190;190	A;G;C	163;160;162	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1024	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	2423	100.7	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1281	1281	T	172	T,A	156,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1024	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	2423	100.7	1	SNP	p	G120K	0	.	.	358	360	GGT	1008	1010	GGT	170;174;171	G;G;T,G	149;152;141,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1024	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	2423	100.7	1	SNP	p	A121N	0	.	.	361	363	GCC	1011	1013	GCC	171;172;172	G;C;C	144;149;152	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1024	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	2423	100.7	1	SNP	p	A121D	0	.	.	361	363	GCC	1011	1013	GCC	171;172;172	G;C;C	144;149;152	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	5032	rpoB	4179	4179	100.0	rpoB.l15.c30.ctg.1	4811	246.8	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1840	1842	AAT	291;288;288	A,C;A;T	257,1;255;255	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	408	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1667	59.2	1	SNP	p	V57M	1	.	.	169	171	ATG	898	900	ATG	132;132;134	A,C;T;G	116,1;120;121	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
